Inhibitory receptors and allergy

Current Opinion in Immunology

Volumn 14, Issue 6, 2002, Pages 698-704

  Katz, Howard R ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G; LECTIN; PROTEIN; RECEPTOR PROTEIN; SIALIC ACID; FC GAMMA RECEPTOR IIB; FC RECEPTOR; GP49A PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; KLRG1 PROTEIN, HUMAN; KLRG1 PROTEIN, MOUSE; KLRG1 PROTEIN, RAT; LEUKOCYTE ANTIGEN; LILRB4 PROTEIN, MOUSE; MEMBRANE PROTEIN; N ACETYLNEURAMINIC ACID; PIRB PROTEIN, MOUSE; PIRB PROTEIN, RAT; TRANSACTIVATOR PROTEIN;

ALLERGY; CELL ACTIVATION; CELL FUNCTION; HUMAN; LEUKOCYTE; MAST CELL; NONHUMAN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; MOUSE; RAT;

ANIMALS; ANTIGENS, CD; HUMANS; HYPERSENSITIVITY; LECTINS; LECTINS, C-TYPE; LEUKOCYTES; MAST CELLS; MEMBRANE GLYCOPROTEINS; MICE; N-ACETYLNEURAMINIC ACID; RATS; RECEPTORS, IGG; RECEPTORS, IMMUNOLOGIC; TRANS-ACTIVATORS;

EID: 0036888570     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00400-4     Document Type: Review

References (71)

1. Muta T., Kurosaki T., Misulovin Z., Sanchez M., Nussenzweig M.C., Ravetch J.V. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature. 368:1994;70-73.
2. Hulett M.D., McKenzie I.F.C., Hogarth P.M. Chimeric Fc receptors identify immunoglobulin-binding regions in human FcγRII and FcεRI. Eur J Immunol. 23:1993;640-645.
3. Daëron M., Malbec O., Latour S., Arock M., Fridman W.H. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest. 95:1995;577-585.
4. Daëron M., Latour S., Malbec O., Espinosa E., Pina P., Pasmans S., Fridman W.H. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity. 3:1995;635-646.
5. Ono M., Bolland S., Tempst P., Ravetch J.V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature. 383:1996;263-266.
6. 2+ following B-cell receptor activation. EMBO J. 17:1998;1973-1985.
7. Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S., Gout I., Cantley L.C., Rawlings D.J., Kinet J.P. Phosphatidylinositol-3,4,5-trisphosphate (Ptdins-3,4,5-p3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1998;1961-1972.
8. Bolland S., Pearse R.N., Kurosaki T., Ravetch J.V. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity. 8:1998;509-516.
9. Tamir I., Stolpa J.C., Helgason C.D., Nakamura K., Bruhns P., Daeron M., Cambier J.C. The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity. 12:2000;347-358.
10. dok, is a mediator of FcγRIIB inhibition of FcεRI signaling. J Immunol. 168:2002;4430-4439.
11. Takai T., Ono M., Hikida M., Ohmori H., Ravetch J.V. Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature. 379:1996;346-349.
12. Miyajima I., Dombrowicz D., Martin T.R., Ravetch J.V., Kinet J.P., Galli S.J. Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis. J Clin Invest. 99:1997;901-914.
13. Yamaguchi M., Lantz C.S., Oettgen H.C., Katona I.M., Fleming T., Miyajima I., Kinet J.P., Galli S.J. IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med. 185:1997;663-672.
14. MacGlashan D., McKenzie-White J., Chichester K., Bochner B.S., Davis F.M., Schroeder J.T., Lichtenstein L.M. In vitro regulation of FcεRI-α expression on human basophils by IgE antibody. Blood. 91:1998;1633-1643.
15. Ujike A., Ishikawa Y., Ono M., Yuasa T., Yoshino T., Fukumoto M., Ravetch J.V., Takai T. Modulation of immunoglobulin (Ig) E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med. 189:1999;1573-1579.
16. Takizawa F., Adamczewski M., Kinet J.-P. Identification of the low affinity receptor for immunoglobulin E on mouse mast cells and macrophages as FcγRII and FcγRIII. J Exp Med. 176:1992;469-476.
17. v mice. Cell Mol Life Sci. 54:1998;456-460.
18. Rudge E.U., Cutler A.J., Pritchard N.R., Smith K.G. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and Fc(RII-mediated B cell suppression. J Exp Med. 195:2002;1079-1085. This paper establishes the principle that IL-4 exerts a positive effect on B cell activation through downregulation of ITIM-bearing receptors. The findings uncovered a novel positive feedback loop for Th2 responses through an IL-4-mediated reduction in inhibition afforded by ITIM receptors.
19. Katz H.R., Benson A.C., Austen K.F. Activation- and phorbol ester-stimulated phosphorylation of a plasma membrane glycoprotein antigen expressed on mouse IL-3-dependent mast cells and serosal mast cells. J Immunol. 142:1989;919-926.
20. LeBlanc P.A., Russell S.W., Chang S.-M.T. Mouse mononuclear phagocyte heterogeneity detected by monoclonal antibodies. J Reticuloendothelial Soc. 32:1982;219-231.
21. Rojo S., Burshtyn D.N., Long E.O., Wagtmann N. Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells. J Immunol. 158:1997;9-12.
22. Wang L.L., Mehta I.K., LeBlanc P.A., Yokoyama W.M. Mouse natural killer cells express gp49B1, a structural homolog of human killer inhibitory receptors. J Immunol. 158:1997;13-17.
23. Katz H.R., Vivier E., Castells M.C., McCormick M.J., Chambers J.M., Austen K.F. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc Natl Acad Sci USA. 93:1996;10809-10814.
24. Matsumoto Y., Wang L.L., Yokoyama W.M., Aso T. Uterine macrophages express the gp49B inhibitory receptor in midgestation. J Immunol. 166:2001;781-786.
25. Lu-Kuo J.M., Joyal D.M., Austen K.F., Katz H.R. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of the src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J Biol Chem. 274:1999;5791-5796.
26. Castells M.C., Klickstein L.B., Hassani K., Cumplido J., Lacouture M.E., Austen K.F., Katz H.R. gp49B1-αvβ3 interaction inhibits antigen-induced mast cell activation. Nat Immunol. 2:2001;436-442.
27. Daheshia M., Friend D.S., Grusby M.J., Austen K.F., Katz H.R. Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice. J Exp Med. 194:2001;227-233. This paper established that gp49B1 constitutively inhibits activation of mast cells induced in vivo by Ig produced through the adaptive immune response.
28. Hayami K., Fukuta D., Nishikawa Y., Yamashita Y., Inui M., Ohyama Y., Hikida M., Ohmori H., Takai T. Molecular cloning of novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors. J Biol Chem. 272:1997;7320-7337.
29. Kubagawa H., Burrows P.D., Cooper M.D. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA. 94:1997;5261-5266.
30. Kubagawa H., Chen C.C., Ho L.H., Shimada T.S., Gartland L., Mashburn C., Uehara T., Ravetch J.V., Cooper M.D. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B. J Exp Med. 189:1999;309-318.
31. Blery M., Kubagawa H., Chen C.-C., Vely F., Cooper M.D., Vivier E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA. 95:1998;2446-2451.
32. Maeda A., Kurosaki M., Ono M., Takai T., Kurosaki T. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal. J Exp Med. 187:1998;1355-1360.
33. Yamashita Y., Ono M., Takai T. Inhibitory and stimulatory functions of paired Ig-Like receptor (PIR) family in RBL-2H3 cells. J Immunol. 161:1998;4042-4047.
34. Uehara T., Blery M., Kang D.W., Chen C.C., Ho L.H., Gartland G.L., Liu F.T., Vivier E., Cooper M.D., Kubagawa H. Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J Clin Invest. 108:2001;1041-1050. This report established that SHP-1 is dispensable for the inhibition of mast cell activation by PIR-B, and that an ITIM that does not bind SHP-1 plays a key role in the ability of PIR-B to inhibit activation.
35. Ho L.H., Uehara T., Chen C.C., Kubagawa H., Cooper M.D. Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B. Proc Natl Acad Sci USA. 96:1999;15086-15090.
36. -/- mice. Nat Immunol. 3:2002;542-548. This paper demonstrated that PIR-B suppresses B cell activation in vivo, a finding previously limited to in vitro studies. Importantly, the paper presents the unexpected finding that PIR-B also inhibits Th2 polarized responses through suppression of dendritic cells.
37. Arm J.P., Nwankwo C., Austen K.F. Molecular identification of a novel family of human immunoglobulin superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J Immunol. 159:1997;2342-2349.
38. Borges L., Hsu M.-L., Fanger N., Kubin M., Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 159:1997;5192-5196.
39. Cella M., Dohring C., Samaridis J., Dessing M., Brockhaus M., Lanzavecchia A., Colonna M. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J Exp Med. 185:1997;1743-1751.
40. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., Angman L., Cella M., Lopez-Botet M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1997;1809-1818.
41. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., Hsu M.L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273-282.
42. Meyaard L., Adema G.J., Chang C., Woollatt E., Sutherland G.R., Lanier L.L., Phillips J.H. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity. 7:1997;283-290.
43. Samaridis J., Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol. 27:1997;660-665.
44. Colonna M., Samaridis J., Cella M., Angman L., Allen R.L., O'Callaghan C.A., Dunbar R., Ogg G.S., Cerundolo V., Rolink A. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160:1998;3096-3100.
45. Tedla N.T., Tassinari P., Austen K.F., Borges L., Cosman D., Arm J.P. Leukocyte immunoglobulin-like receptors expressed in eosinophils and basophils. FASEB J. 15:2001;A701.
46. Bellon T., Kitzig F., Sayos J., Lopez-Botet M. Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol. 168:2002;3351-3359.
47. Navarro F., Llano M., Bellon T., Colonna M., Geraghty D.E., Lopez-Botet M. The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol. 29:1999;277-283.
48. Chapman T.L., Heikeman A.P., Bjorkman P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity. 11:1999;603-613.
49. Chapman T.L., Heikema A.P., West A.P.J., Bjorkman P.J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity. 13:2000;727-736.
50. Meyaard L., van der Vuurst de Vries A.R., de Ruiter T., Lanier L.L., Phillips J.H., Clevers H. The epithelial cellular adhesion molecule (Ep-CAM) is a ligand for the leukocyte-associated immunoglobulin-like receptor (LAIR). J Exp Med. 194:2001;107-112. This paper established that ligands for the human LIR/LAIR molecules were not limited to MHC class I molecules, but also include adhesion molecules.
51. Angata T., Hingorani R., Varki N.M., Varki A. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J Biol Chem. 276:2001;45128-45136.
52. Yousef G.M., Ordon M.H., Foussias G., Diamandis E.P. Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes. Gene. 286:2002;259-270. This report expands the family of human Siglecs and provides interesting comments on how this newly-appreciated family of ITIM receptors evolved.
53. Valent P., Ashman L.K., Hinterberger W., Eckersberger F., Majdic O., Lechner K., Bettelheim P. Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood. 73:1989;1778-1785.
54. Ghannadan M., Hauswirth A.W., Schernthaner G.H., Muller M.R., Klepetko W., Schatzl G., Sperr W.R., Buhring H.J., Valent P. Detection of novel CD antigens on the surface of human mast cells and basophils. Int Arch Allergy Immunol. 127:2002;299-307.
55. Floyd H., Ni J., Cornish A.L., Zeng Z., Liu D., Carter K.C., Steel J., Crocker P.R. Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem. 275:2000;861-866.
56. Kikly K.K., Bochner B.S., Freeman S.D., Tan K.B., Gallagher K.T., D'alessio K.J., Holmes S.D., Abrahamson J.A., Murdock P.R., Tachimoto H., et al. Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol. 105:2000;1093-1100.
57. Nutku E., Robinson M., Bocher B.S. Function of Siglec-8 on human eosinophils: crosslinking in vitro induces apoptosis that is not rescued by IL-5. J Allergy Clin Immunol. 109:2002;S262.
58. Nitschke L., Floyd H., Ferguson D.J., Crocker P.R. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med. 189:1999;1513-1518.
59. Crocker P.R., Varki A. Siglecs in the immune system. Immunology. 103:2001;137-145.
60. Razi N., Varki A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci USA. 95:1998;7469-7474.
61. Lienard H., Bruhns P., Malbec O., Fridman W.H., Daeron M. Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation. J Biol Chem. 274:1999;32493-32499.
62. Oldenborg P.A., Gresham H.D., Lindberg F.P. CD47-signal regulatory protein alpha (SIRPα) regulates Fcγ and complement receptor-mediated phagocytosis. J Exp Med. 193:2001;855-862.
63. Latour S., Tanaka H., Demeure C., Mateo V., Rubio M., Brown E.J., Maliszewski C., Lindberg F.P., Oldenborg A., Ullrich A., et al. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-(: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol. 167:2001;2547-2554.
64. Ortega E., Schneider H., Pecht I. Possible interactions between the Fcε receptor and a novel mast cell function-associated antigen. Int Immunol. 3:1991;333-342.
65. Geller-Bernstein C., Berrebi A., Bassous G.L., Ortega E., Licht A., Pecht I. Antibodies specific to membrane components of rat mast cells are cross-reacting with human basophils. Int Arch Allergy Immunol. 105:1994;269-273.
66. Hanke T., Corral L., Vance R.E., Raulet D.H. 2F1 antigen, the mouse homolog of the rat 'mast cell function-associated antigen', is a lectin-like type II transmembrane receptor expressed by natural killer cells. Eur J Immunol. 28:1998;4409-4417.
67. Blaser C., Kaufmann M., Pircher H. Virus-activated CD8 T cells and lymphokine-activated NK cells express the mast cell function-associated antigen, an inhibitory C-type lectin. J Immunol. 161:1998;6451-6454.
68. Guthmann M.D., Tal M., Pecht I. A new member of the C-type lectin family is a modulator of the mast cell secretory response. Int Arch Allergy Immunol. 107:1995;82-86.
69. Philosof-Oppenheimer R., Hampe C.S., Schlessinger K., Fridkin M., Pecht I. An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases. Eur J Biochem. 267:2000;703-711.
70. Xu R., Abramson J., Fridkin M., Pecht I. SH2 domain-containing inositol polyphosphate 5′-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen. J Immunol. 167:2001;6394-6402.
71. Echtenacher B., Männel D.N., Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 381:1996;75-77.